Ecological momentary assessment (EMA) enables the collection of real-time data on individuals’ feelings, behaviors, and contexts through repeated short assessments, typically delivered via smartphones. Despite its value for understanding everyday determinants of well-being, EMA is less commonly implemented than traditional, retrospective self-report methods in many applied and community-based research settings, in part because of the […]
This man with ALS is “the first power user” of a brain implant that lets him speak
Casey Harrell has had a set of electrodes embedded in his brain for almost three years. Harrell, who has amyotrophic lateral sclerosis (ALS) and is paralyzed, first used his brain-computer interface (BCI) to “speak” sentences with the help of a research team in 2023. Since then, Harrell has clocked thousands of hours of use. He […]
Eisai claims UK grant to expand manufacturing site
Eisai has been given a grant from the UK that will support a £48m plan to add cold chain capabilities to its facility in Hatfield, Hertfordshire.
US Cracks Down on Anthropic AI Models Amid Abuse Concerns
Anthropic abruptly suspended all access to Fable 5 and Mythos 5 after receiving an export control directive that banned foreign nationals from using the technology.
Key pipeline drug for Lundbeck delivers in Cushing syndrome
Lundbeck has reported positive trial results with Cushing’s therapy asedebart, a key R&D prospect as it faces a patent cliff in the next few years.
Data could move J&J’s Talvey earlier in myeloma therapy
Johnson & Johnson’s Talvey looks set to move second-line in multiple myeloma treatment, based on the results of the MonumenTAL-3 trial at EHA 2026.
Advancing women’s health through equity in quantitative sciences: promoting sex- and gender-based modeling in clinical trials and real-world studies
Post Content
NHS study launched to tackle antimicrobial resistance threat
A new study will attempt to improve screening for CPE, one of the fastest-growing drug-resistant bacterial threats facing hospitals in England.
AZ’s Truqap and Roche assay cleared for PTEN prostate cancer
AstraZeneca has claimed a second approval for AKT inhibitor Truqap, in prostate cancer, that should help achieve its blockbuster hopes for the drug.
Crisis support teams’ technological openness and learning attitudes toward the AI based virtual patient system crisis support VR
BackgroundAgainst the backdrop of escalating global humanitarian crises, innovative didactic simulations are becoming increasingly important. A promising alternative to traditional classroom-based didactics for learning psychological first aid (PFA) prior to humanitarian crises is to use generative artificial intelligence (GenAI)-based virtual patient (VP) systems. However, there is limited research on the use of GenAI-based VP systems […]
Trauma-informed conversational agents for mental health: understanding user perspectives and experiences
IntroductionMental health conversational agents (MHCAs) offer scalable, accessible psychological support yet raise concerns about safety and appropriateness for trauma, exposed users. While trauma-informed care (TIC) principles, emphasizing safety, trust, empowerment, collaboration, peer support, and cultural sensitivity, are well-established in clinical practice, their application and user interpretation in chatbot contexts remain unexplored. This study aimed to […]
Learning Urban Access Costs from Origin-Destination Flows via Inverse Optimal Transport
arXiv:2606.14157v1 Announce Type: cross Abstract: Cities deliver basic services through mixed public-private facility networks, including schools, clinics, transit providers, and subsidized service points. In these systems, planners often observe where households go, but not the latent cost function through which they trade off factors such as distance, price, and institutional access. We study this urban […]